
Please try another search
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd, a biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs. Its products include YISAIPU, a tumor necrosis factor inhibitor type II-antibody fusion protein for the treatment of autoimmune rheumatism and immunology; Septin, an injection for anti-human epidermal growth factor receptor-2 treatment; and Jiannipa, a recombinant anti-CD25 humanized monoclonal antibody injection to prevent acute rejection caused by kidney transplantation. The company was founded in 2002 and is based in Shanghai, China.
Name | Age | Since | Title |
---|---|---|---|
Yanli Liu | 44 | 2019 | GM & Director |
Wei Zhang | 63 | 2019 | Independent Director |
Song You | 62 | 2024 | Independent Director |
Hong Cao | 56 | 2021 | Chairman of the Supervisory Board |
Li Tian | 42 | 2019 | Employee Representative Supervisor |
Yongli Jin | 67 | 2019 | Independent Director |
Jing Wu | 30 | 2021 | Employee Representative Supervisor |
Dongmei Su | 55 | 2022 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review